LOUISVILLE, Colo., July 21, 2026
Synergy Spine Solutions has announced a major commercial milestone for its FDA-approved Synergy Disc®, reporting that the motion-preserving cervical disc replacement device has been successfully implanted in 100 patients across the United States within the first 100 days following its initial commercial procedure. The achievement reflects strong early adoption among spine surgeons seeking alternatives to traditional cervical fusion procedures. Designed to preserve natural spinal motion while restoring cervical alignment, the Synergy Disc combines a unique 6-degree lordotic core with a nickel-free titanium alloy, offering a differentiated solution for patients with degenerative cervical disc disease, including those with nickel sensitivities. The milestone underscores growing interest in next-generation cervical disc replacement technologies that aim to improve patient outcomes through enhanced biomechanics and motion preservation.
FDA-Approved Cervical Disc Gains Rapid Clinical Adoption
Following its U.S. Food and Drug Administration (FDA) Premarket Approval earlier this year for single-level cervical disc replacement at C3-C7, the Synergy Disc® has quickly gained traction among spine surgeons nationwide. According to the company, 98% of the first 100 U.S. procedures utilized the 6-degree lordotic core, highlighting strong physician preference for technologies designed to restore the spine’s natural curvature while maintaining physiological motion. Unlike conventional anterior cervical discectomy and fusion (ACDF) procedures that permanently fuse spinal segments, the Synergy Disc is engineered to preserve movement at the treated level, helping maintain natural cervical biomechanics. Manufactured from time-tested orthopedic materials, including a nickel-free titanium alloy, the implant also supports improved MRI compatibility and expands treatment options for patients with documented nickel allergies, one of the most common metal hypersensitivities worldwide.
Clinical Evidence Demonstrates Superior Patient Outcomes
The commercial milestone builds on encouraging findings from the company’s U.S. Investigational Device Exemption (IDE) clinical study, which demonstrated that the Synergy Disc achieved an 87.1% composite clinical success rate at 24 months, outperforming traditional ACDF surgery for patients with cervical degenerative disc disease. Clinical data further showed that patients receiving the Synergy Disc experienced lower neck and arm pain scores, improved functional outcomes, and higher overall patient satisfaction compared with the fusion control group. Prior to its U.S. approval, the device had already accumulated more than a decade of international clinical experience, with successful implantation in thousands of patients across more than 10 countries. These long-term clinical data have helped support physician confidence as cervical disc replacement continues to evolve toward preserving both spinal motion and anatomical alignment.
Innovation Focuses on Motion Preservation and Alignment Restoration
Synergy Spine Solutions developed the Synergy Disc® in close collaboration with leading spine surgeons to address the growing demand for motion-preserving spinal technologies capable of replicating the spine’s natural biomechanics. The implant’s proprietary 6-degree lordotic core is specifically designed to restore cervical alignment while maintaining mobility, an approach increasingly recognized as an important factor in long-term spinal health. Company executives believe reaching 100 commercial procedures within 100 days reflects increasing surgeon confidence in technologies supported by robust clinical evidence and proven international experience. As demand for motion-preserving cervical disc replacement continues to grow, Synergy Spine Solutions plans to expand access while supporting physician education and maintaining a careful commercial rollout of its innovative spinal implant technology, positioning the Synergy Disc as an important advancement in the future of cervical spine surgery.
Source: Synergy Spine Solutions Press release



